Tỷ lệ và tỷ lệ mắc, sử dụng tài nguyên và chi phí tài chính trong điều trị bệnh nhân mắc rối loạn tăng động giảm chú ý (ADHD) ở Vương quốc Anh (1998 đến 2010)
Tóm tắt
Rối loạn tăng động giảm chú ý (ADHD) là một rối loạn phổ biến thường xuất hiện ở trẻ em và liên quan đến việc sử dụng tài nguyên chăm sóc sức khỏe nhiều hơn. Mục đích của nghiên cứu này là để mô tả đại dịch học của ADHD đã được chẩn đoán ở Vương quốc Anh và xác định sự sử dụng tài nguyên và chi phí tài chính của việc chăm sóc.
Trong nghiên cứu đoàn hệ quan sát hồi cứu này, các bệnh nhân mới được chẩn đoán ADHD từ năm 1998 đến 2010 được xác định từ Datalink Nghiên cứu Thực hành Lâm sàng Vương quốc Anh (CPRD) và được ghép nối với một nhóm đối chứng được chọn ngẫu nhiên không có chẩn đoán ADHD. Tỷ lệ mắc và tỷ lệ chẩn đoán ADHD đã được tính toán. Sự sử dụng tài nguyên và các chi phí tài chính tương ứng sau khi chẩn đoán đã được ước lượng cho các cuộc liên hệ với bác sĩ gia đình, các cuộc điều tra, đơn thuốc, các cuộc hẹn ngoại trú và nhập viện.
Từ khóa
Tài liệu tham khảo
Ford T, Goodman R, Meltzer H: The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders. J Am Acad Child Psy. 2003, 42: 1203-1211. 10.1097/00004583-200310000-00011.
Prescribing & medicines: medicines used in mental health. Financial years 2001/02 – 2010/11.http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Publications/2011-09-27/2011-09-27-PrescribingMentalHealth-Summary.pdf?96236819029.
Hospital prescribing, England. 2010,http://www.ic.nhs.uk/pubs/hospre10.
Harpin V a: The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child. 2005, 90 (Suppl 1): i2-i7.
Bagwell CL, Molina BS, Pelham WE, Hoza B: Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry. 2001, 40: 1285-1292. 10.1097/00004583-200111000-00008.
Kadesjo B, Gillberg C: The comorbidity of ADHD in the general population of Swedish school-age children. J Child Psychol Psychiat. 2001, 42: 487-492. 10.1111/1469-7610.00742.
Johnston C, Mash EJ: Families of children with attention-deficit/hyperactivity disorder: review and recommendations for future research. Clin Child Fam Psychol Rev. 2001, 4: 183-207. 10.1023/A:1017592030434.
Ray GT, Levine P, Croen LA, Bokhari F, Hu T-W, Habel L: Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity. Arch Pediatr & Adolesc Med. 2006, 160: 1063-1069. 10.1001/archpedi.160.10.1063.
Guevara J, Lozano P, Wickizer T, Mell L, Gephart H: Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics. 2001, 108: 71-78. 10.1542/peds.108.1.71.
Leibson C, Katusic S, Barbaresi WJ, Ransom J, Brien PCO: Use and costs of medical care for children attention-deficit/hyperactivity disorder. JAMA. 2001, 285: 60-66. 10.1001/jama.285.1.60.
Chan E, Zhan C, Homer CJ: Health care Use and costs for children with attention-deficit/hyperactivity disorder. Arch Pediat Adol Med. 2002, 156: 504-511. 10.1001/archpedi.156.5.504.
Pelham WE, Foster EM, Robb J a: The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Ambul Pediatr. 2007, 7 (1 Suppl): 121-131.
Matza LS, Paramore C, Prasad M: A review of the economic burden of ADHD. Cost Eff Resour Alloc. 2005, 3: 5-10.1186/1478-7547-3-5.
Birnbaum H, Kessler R, Lowe S, Secnik K, Greenberg P, Leong S, Swensen A: Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin. 2005, 21: 195-206. 10.1185/030079904X20303.
Hakkaart-van Roijen L, Zwirs BWC, Bouwmans C, Tan SS, Schulpen TWJ, Vlasveld L, Buitelaar JK: Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adoles Psy. 2007, 16: 316-326. 10.1007/s00787-007-0603-6.
ADHD: diagnosis and management of ADHD in children, young people and adults. NICE Clinical Guideline 72.http://www.nice.org.uk/nicemedia/pdf/adhdfullguideline.pdf.
Use of ADHD drugs “increases by 50% in six years”.http://www.bbc.co.uk/news/health-23674235.
ADHD services over Scotland final report.http://www.healthcareimprovementscotland.org/our_work/mental_health/adhd_service_improvement/stage_3_adhd_final_report.aspx.
Clinical practice research datalink.http://www.cprd.com/intro.asp.
Committee on Safety of Medicines and Medicines Control Agency: Volital (Pemoline) has been withdrawn. Current Problems in Pharmacovigilance. 1997, 23: 10.
British National Formulary (online).http://www.medicinescomplete.com.
Prescriptions cost analysis – England. 2011,http://www.ic.nhs.uk/pubs/prescostanalysis2011.
Prescribing.http://www.hscic.gov.uk/prescribing.
Prescription cost analysis, England. 2010,http://www.ic.nhs.uk/catalogue/PUB02274/pres-cost-anal-eng-2010-apx.pdf.
HM Treasury: Economic data and tools. Latest figures.http://www.hm-treasury.gov.uk/data_gdp_fig.htm.
Tariff information: confirmation of payment by results (PbR) arrangements for 2010–2011.http://data.gov.uk/dataset/payment-by-results-2010-11-national-tariff-information.
NHS reference costs 2010–2011.http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_131140.
Health Statistics Wales 2011.http://wales.gov.uk/topics/statistics/publications/publication-archive/health2011/?lang=en.
NHS National Services Scotland.http://www.isdscotland.org/.
NHS pathology: pathology solutions.http://www.nhspathology.fph.nhs.uk/.
Unit costs of health and social care. 2011,http://www.pssru.ac.uk/archive/pdf/uc/uc2011/uc2011.pdf.
GP workload survey.http://www.ic.nhs.uk/pubs/gpworkload.
Downloads: costing.http://www.ic.nhs.uk/casemix/costing.
NHS Reference Costs 2009–2010.https://www.gov.uk/government/publications/nhs-reference-costs-2009-2010.
Polanczyk G, De Lima MS, Horta BL, Biederman J, Rohde LA: The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007, 164: 942-948. 10.1176/appi.ajp.164.6.942.
Sayal K, Taylor E, Beecham J, Byrne P: Pathways to care in children at risk of attention-deficit hyperactivity disorder. Br J Psychiatry. 2002, 181: 43-48. 10.1192/bjp.181.1.43.
Sayal K, Goodman R, Ford T: Barriers to the identification of children with attention deficit/hyperactivity disorder. J Child Psychol Psychiatry. 2006, 47: 744-750. 10.1111/j.1469-7610.2005.01553.x.
Jick H, Kaye JA, Black C: Incidence and prevalence of drug-treated attention deficit disorder among boys in the UK. Br J Gen Pract. 2004, 54: 345-347.
Klasen H, Goodman R: Parents and GPs at cross-purposes over hyperactivity: a qualitative study of possible barriers to treatment. Br J Gen Pract. 2000, 50: 199-202.
Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS: Prevalence, Recognition, and Treatment of Attention-Deficit/Hyperactivity Disorder in a National Sample of US Children. Arch Paediat Adol Med. 2007, 161: 857-864. 10.1001/archpedi.161.9.857.
Morbidity and Mortality Weekly Report (MMWR). Increasing Prevalence of Parent-Reported Attention-Deficit/Hyperactivity Disorder Among Children - United States, 2003 and 2007.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5944a3.htm.
Attention Deficit and Hyperkinetic Disorders – Services Over Scotland (ADHD-SOS) Follow-up Review.http://www.healthcareimprovementscotland.org/his/idoc.ashx?docid=c3c72452-cb24-4179-bdba-13be65b74c3d&version=−1.
McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, De Soysa R, Taylor E, Williams T, Wong ICK: Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry. 2009, 194: 273-277. 10.1192/bjp.bp.107.045245.
Kooij J, Buitelaar J, Van den Oord E, Furer J, Rijnders C, Hodiamont P: Internal and external validity of Attention-Deficit Hyperactivity Disorder in a population-based sample of adults. Psychol Med. 2004, 34: 1-11.
Berry CA, Shaywitz SE, Shaywitz BA: Girls with attention deficit disorder: a silent minority? A report on behavioral and cognitive characteristics. Pediatrics. 1985, 76: 801-809.
Pastor PN, Reuben C a: Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004–2006. Vital Health Stat. 2008, 10: 1-14.
Simon V, Czobor P, Bálint S, Mészáros A, Bitter I: Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009, 194: 204-211. 10.1192/bjp.bp.107.048827.
Faraone SV, Biederman J, Mick E: The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006, 36: 159-165.
Office for National Statistics: Population estimates quinary age groups for UK constituent countries – mid 1971 to mid 2010.http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk--england-and-wales--scotland-and-northern-ireland/population-estimates-timeseries-1971-to-current-year/index.html.
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al: The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiat. 2006, 163: 716-723. 10.1176/appi.ajp.163.4.716.
King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R: A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol Asses. 2006, 10: 1-146.
Telford C, Green C, Logan S, Langley K, Thapar A, Ford T: Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder. Soc Psychiatry Psychiatr Epidemiol. 2013, 48: 337-344. 10.1007/s00127-012-0530-9.
Gallagher A, Puri S, Van Staa T: Linkage of the General Practice Research Database (GPRD) with other data sources. Pharmacoepidemiol Drug Saf. 2011, 20: S1-S364.
Khan NF, Harrison SE, Rose PW: Validity of diagnostic coding within the General Practice Research Database : a systematic review. Brit J Gen Pract. 2010, 60: e128-e136. 10.3399/bjgp10X483562.